Global Prostate Cancer Diagnosis & Treatment Market Research and Analysis, 2015-2022

  • ID: 4320265
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Dec 31st 2018
1 of 5
The Global Prostate Cancer Market is Expected to Grow at the CAGR of 10.2% During 2017-2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie
  • Astellas Pharma, Inc.
  • AstraZeneca Plc
  • Ipsen SA
  • Johnson & Johnson
  • MORE
Market Insights

The Global Prostate Cancer Market is expected to grow at the CAGR of 10.2 % during 2017-2022. The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe. Prostate cancer is an androgen-dependent disease that responds to medicine and treatment in the initial stages, however in the later stages it becomes resistant to therapies and other treatments. There are certain risk and causes of prostate cancer which includes age, ethnicity, family history and genes, being overweight or obese, IGF-1 (Insulin like growth factor), vasectomy, inflammation of the prostate and so on. Prostate cancer results into abnormal and uncontrolled growth of cells in prostate gland of men. It majorly affects men of developed region with age 50 and above. The U.S. contributes highest in prostate cancer market due to prevalence of prostate cancer and adoption of innovative surgeries and treatments. According to WHO, in 2012 more than 14 million new cases of cancer and 8.2 million cancer fatalities were registered. The trend is expected to continue with new cases to increase over 70%. Early diagnosis, innovative treatment methods and quality care of the patients may enable to survive prostate cancer patients.

Global rise in prostate cancer and adoption of minimally invasive surgeries are driving the market growth across the globe. There are other factors that are boosting the market growth of Global Prostate Cancer Market it includes R&D, rise in grants and funding, increasing adoption of personalized medicines, growing pharmaceutical industries and so on. Rising diagnostic centers across the globe, investment from government and private players have bolstered the market growth. Successful clinical trials and FDA approval will influence the prostate cancer market in near future.

Geographical Insights:

North America and Europe has considerable contribution in the growth of Global Prostate Cancer Market followed by APAC region. The key driving forces includes rising incidence and prevalence of prostate cancer and adoption of innovative surgeries and treatment across the globe. Emerging economies such as China, India, Japan and Korea have huge population of cancer patients. Technological advancement, innovation and improved healthcare spending will drive the APAC region. Improved standard of living, infrastructural development and favorable government policies are some other factors that will boost prostate cancer market in APAC region.

Competitive Insights:

Some of the key players contributing significantly in the growth of prostate cancer market includes Abbott Laboratories, Abbvie, Johnson & Johnson, AstraZeneca Plc, Astellas Pharma, Inc., Sanofi, Medivation, Inc., Ipsen SA and Bayer Healthcare Pharmaceutical, Inc. Prostate cancer market companies are constantly focusing on product launch, R&D, partnerships, M&A, innovation and technological advancement. The report also includes detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, predictive analysis, pipeline analysis, market determinants, market segmentation, geographical analysis, company profiling of the market.

Market Segmentation:
  • Global Prostate Cancer Market Research And Analysis, By Diagnostic Techniques
  • Global Prostate Cancer Market Research And Analysis, By Radiation Therapy
  • Global Prostate Cancer Market Research And Analysis, By Surgery
  • Global Prostate Cancer Market Research And Analysis, By Chemotherapy
Report covers:
  • Comprehensive research methodology of Global Prostate Cancer Market.
  • This report also includes detailed and extensive market overview with current market recommendations & key analysts insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Prostate Cancer Market.
  • Insights about market determinants which are stimulating the Global Prostate Cancer Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie
  • Astellas Pharma, Inc.
  • AstraZeneca Plc
  • Ipsen SA
  • Johnson & Johnson
  • MORE
Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders
1.2.4. Exceptions

Market Overview and Insights
2.1. Definition
2.3. Current Market Trends & Analyst Insight
2.3.1. Key Findings
2.3.2. Recommendation
2.3.3. Conclusion
2.4. Pipeline Analysis
2.5. Regulation

Market Determinant
3.1. Motivators
3.1.1. Rise in Incidence & Prevalence Rate of Cancer Diseases
3.1.2. Growing Investment and Grants from Government and Private Players
3.1.3. Increasing Obese and Over-Weight Population Across the Globe
3.1.4. Research & Development in Prostate Cancer Market
3.1.5. Rising Adoption of Personalized Medicines
3.1.6. Technological Advancement and Innovation
3.2. Restraint
3.2.1. High Cost of Global Prostate Cancer Drugs and Surgeries
3.2.2. Reimbursement Policies May Affect the Growth of the Market
3.2.3. Surgical Risks and Side Effects
3.3. Opportunity
3.3.1. Untapped Apac Region Have Huge Opportunity for Global Prostate Cancer Market
3.3.2. Successful Clinical Trials and Fda Approvals
3.3.3. Rise in Diagnostic Centers Across the Globe
3.3.4. Growth in Pharmaceutical Market of Prostate Cancer

Market Segmentation
4.1. Global Prostate Cancer Market Research and Analysis, by Diagnostic Techniques
4.1.1. Prostate Specific Antigen Test (Psa)
4.1.2. Digital Rectal Exam (Dre)
4.2. Global Prostate Cancer Market Research and Analysis, by Radiation Therapy
4.2.1. Brachytherapy
4.2.1.1. Temporary Brachytherapy
4.2.1.2. Permanent Brachytherapy
4.2.2. External Beam Radiation Therapy
4.2.2.1. Stereotactic Body Radiation Therapy
4.2.2.2. Proton Beam Radiation Therapy
4.2.2.3. 3D Conformal Radiation Therapy
4.2.2.4. Intensity Modulated Radiation Therapy
4.3. Digital Rectal Exam (Dre) Global Prostate Cancer Market Research and Analysis, by Surgery
4.3.1. Radical Prostatectomy
4.3.2. Trans Urethral Resection (Tur)
4.3.3. Orchidectomy
4.4. Digital Rectal Exam (Dre) Global Prostate Cancer Market Research and Analysis, by Chemotherapy
4.4.1. Docetaxel
4.4.2. Vinorelbine
4.4.3. Carboplatin
4.4.4. Etoposide
4.4.5. Vinblastine

Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

Regional Analysis
6.1. North American Market
6.1.1. United States
6.1.1.1. Canada
6.1.1.2. Rest of North America
6.1.2. European Market
6.1.2.1. Uk
6.1.2.2. Germany
6.1.2.3. Spain
6.1.2.4. France
6.1.2.5. Italy
6.1.2.6. Rest of Europe
6.1.3. Asia Pacific Market
6.1.3.1. India
6.1.3.2. China
6.1.3.3. Japan
6.1.3.4. Rest of Asia Pacific
6.1.4. Rest of the World

Company Profiles
7.1. Abbott Laboratories
7.1.1. Introduction
7.1.2. Abbott Laboratories Product Portfolio
7.1.3. Abbott Laboratories Recent Activities
7.2. Abbvie
7.2.1. Introduction
7.2.2. Abbvie Product Portfolio
7.2.3. Abbvie Recent Activities
7.3. Active Biotech
7.3.1. Introduction
7.3.2. Active Biotech Product Portfolio
7.3.3. Active Biotech Recent Activities
7.4. Amgen
7.4.1. Introduction
7.4.2. Amgen Product Portfolio
7.4.3. Amgen Recent Activities
7.5. Astellas Pharma Inc
7.5.1. Introduction
7.5.2. Astellas Pharma Inc Product Portfolio
7.5.3. Astellas Pharma Inc Recent Activities
7.6. Astrazeneca
7.6.1. Introduction
7.6.2. Astrazeneca Product Portfolio
7.6.3. Astrazeneca Recent Activities
7.6.4. Astrazeneca SWOTanalysis
7.7. Bavarian Nordic
7.7.1. Introduction
7.7.2. Bavarian Nordic Product Portfolio
7.7.3. Bavarian Nordic Recent Activities
7.8. Bayer
7.8.1. Introduction
7.8.2. Bayer Product Portfolio
7.8.3. Bayer Recent Activities
7.9. Bristol-Myers Squibb
7.9.1. Introduction
7.9.2. Bristol-Myers Squibb Product Portfolio
7.9.3. Bristol-Myers Squibb Recent Activities
7.10. Dendreon
7.10.1. Introduction
7.10.2. Dendreon Product Portfolio
7.10.3. Dendreon Recent Activities
7.11. Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc)
7.11.1. Introduction
7.11.2. Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) Product Portfolio
7.11.3. Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) Recent Activities
7.12. Ferring Pharmaceuticals
7.12.1. Introduction
7.12.2. Ferring Pharmaceuticals Product Portfolio
7.12.3. Ferring Pharmaceuticals Recent Activities
7.13. Ge Healthcare
7.13.1. Introduction
7.13.2. Ge Healthcare Product Portfolio
7.13.3. Ge Healthcare Recent Activities
7.14. Glaxosmithkline
7.14.1. Introduction
7.14.2. Glaxosmithkline Product Portfolio
7.14.3. Glaxosmithkline Recent Activities
7.15. Ipsen
7.15.1. Introduction
7.15.2. Ipsen Product Portfolio
7.15.3. Ipsen Recent Activities
7.16. Johnson & Johnson
7.16.1. Introduction
7.16.2. Johnson & Johnson Product Portfolio
7.16.3. Johnson & Johnson Recent Activities
7.17. Pfizer, Inc.
7.17.1. Introduction
7.17.2. Pfizer, Inc. Product Portfolio
7.17.3. Pfizer, Inc. Recent Activities
7.17.4. Pfizer, Inc. SWOTanalysis
7.18. Sanofi
7.18.1. Introduction
7.18.2. Sanofi Product Portfolio
7.18.3. Sanofi Recent Activities
7.19. Seimens Healthcare
7.19.1. Introduction
7.19.2. Seimens Healthcare Product Portfolio
7.19.3. Seimens Healthcare Recent Activities
7.20. Takeda Pharmaceutical Co. Ltd
7.20.1. Introduction
7.20.2. Takeda Pharmaceutical Co. Ltd Product Portfolio
7.20.3. Takeda Pharmaceutical Co. Ltd Recent Activities
7.21. Teva Pharmaceutical
7.21.1. Introduction
7.21.2. Teva Pharmaceutical Product Portfolio
7.21.3. Teva Pharmaceutical Recent Activities
7.22. Tolmar Inc
7.22.1. Introduction
7.22.2. Tolmar Inc Product Portfolio
7.22.3. Tolmar Inc Recent Activities

List of Tables
Table 1 Global Prostate Cancer Market Research and Analysis, by Diagnostic Techniques
Table 2 Prostate Specific Antigen Test (Psa)
Table 3 Digital Rectal Exam (Dre)
Table 4 Global Prostate Cancer Market Research and Analysis, by Radiation Therapy
Table 5 Brachytherapy
Table 6 Temporary Brachytherapy
Table 7 Permanent Brachytherapy
Table 8 External Beam Radiation Therapy
Table 9 Stereotactic Body Radiation Therapy
Table 10 Proton Beam Radiation Therapy
Table 11 3D Conformal Radiation Therapy
Table 12 Intensity Modulated Radiation Therapy
Table 13 Digital Rectal Exam (Dre) Global Prostate Cancer Market Research and Analysis, by Surgery
Table 14 Radical Prostatectomy
Table 15 Trans Urethral Resection (Tur)
Table 16 Orchidectomy
Table 17 Digital Rectal Exam (Dre) Global Prostate Cancer Market Research and Analysis, by Chemotherapy
Table 18 Docetaxel
Table 19 Vinorelbine
Table 20 Carboplatin
Table 21 Etoposide
Table 22 Vinblastine
Table 23 Abbott Laboratories Product Portfolio
Table 24 Abbott Laboratories Recent Activities
Table 25 Abbvie Product Portfolio
Table 26 Abbvie Recent Activities
Table 27 Active Biotech Product Portfolio
Table 28 Active Biotech Recent Activities
Table 29 Amgen Product Portfolio
Table 30 Amgen Recent Activities
Table 31 Astellas Pharma Inc Product Portfolio
Table 32 Astellas Pharma Inc Recent Activities
Table 33 Astrazeneca Product Portfolio
Table 34 Astrazeneca Recent Activities
Table 35 Introduction
Table 36 Bavarian Nordic Product Portfolio
Table 37 Bavarian Nordic Recent Activities
Table 38 Bayer Product Portfolio
Table 39 Bayer Recent Activities
Table 40 Bristol-Myers Squibb Product Portfolio
Table 41 Bristol-Myers Squibb Recent Activities
Table 42 Dendreon Product Portfolio
Table 43 Dendreon Recent Activities
Table 44 Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) Product Portfolio
Table 45 Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) Recent Activities
Table 46 Ferring Pharmaceuticals Product Portfolio
Table 47 Ferring Pharmaceuticals Recent Activities
Table 48 Ge Healthcare Product Portfolio
Table 49 Ge Healthcare Recent Activities
Table 50 Glaxosmithkline Product Portfolio
Table 51 Glaxosmithkline Recent Activities
Table 52 Ipsen Product Portfolio
Table 53 Ipsen Recent Activities
Table 54 Johnson & Johnson Product Portfolio
Table 55 Johnson & Johnson Recent Activities
Table 56 Pfizer, Inc. Product Portfolio
Table 57 Pfizer, Inc. Recent Activities
Table 58 Sanofi Product Portfolio
Table 59 Sanofi Recent Activities
Table 60 Seimens Healthcare Product Portfolio
Table 61 Seimens Healthcare Recent Activities
Table 62 Takeda Pharmaceutical Co. Ltd Product Portfolio
Table 63 Takeda Pharmaceutical Co. Ltd Recent Activities
Table 64 Teva Pharmaceutical Product Portfolio
Table 65 Teva Pharmaceutical Recent Activities
Table 66 Tolmar Inc Product Portfolio
Table 67 Tolmar Inc Recent Activities

List of Figures
Figure 1 North American Market Research and Analysis, 2015-2022 ($ Million)
Figure 2 United States Market Research and Analysis, 2015-2022 ($ Million)
Figure 3 Canada Market Research and Analysis, 2015-2022 ($ Million)
Figure 4 European Market Research and Analysis, 2015-2022 ($ Million)
Figure 5 Uk Market Research and Analysis, 2015-2022 ($ Million)
Figure 6 Germany Market Research and Analysis, 2015-2022 ($ Million)
Figure 7 Spain Market Research and Analysis, 2015-2022 ($ Million)
Figure 8 France Market Research and Analysis, 2015-2022 ($ Million)
Figure 9 Italy Market Research and Analysis, 2015-2022 ($ Million)
Figure 10 Roe Market Research and Analysis, 2015-2022 ($ Million)
Figure 11 Asia Pacific Market Research and Analysis, 2015-2022 ($ Million)
Figure 12 India Market Research and Analysis, 2015-2022 ($ Million)
Figure 13 China Market Research and Analysis, 2015-2022 ($ Million)
Figure 14 Japan Market Research and Analysis, 2015-2022 ($ Million)
Figure 15 Ropac Market Research and Analysis, 2015-2022 ($ Million)
Figure 16 Rest of the World Market Research and Analysis, 2015-2022 ($ Million)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Abbvie
  • Johnson & Johnson
  • AstraZeneca Plc
  • Astellas Pharma, Inc.
  • Sanofi
  • Medivation, Inc.
  • Ipsen SA
  • Bayer Healthcare Pharmaceutical, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll